Evidence map›Paper›PMID 39338471›Full record

ReviewMicroorganisms2024

Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.

John J Rajasekaran, Hari Krishnan Krishnamurthy, Jophi Bosco, Vasanth Jayaraman, Karthik Krishna, Tianhao Wang, Kang Bei

Registry-linked trialAbstract readReview
In one paragraph

Review in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07235826 (Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children), which is not on this map. Cited by 205 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07235826 nacompletednot on this mapstarted 2025, after this paper: background citation

Evaluation of the Efficacy of Streptococcus Salivarius Evol12® in the Reduction of Recurrent Adenotonsillitis in Children: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Cross-over Clinical Trial

TypeinterventionalSponsorLiaquat University of Medical & Health SciencesRan2025 to 2026Enrolled216ConditionsRecurrent TonsillitisArmsBactoblis® Evol (Streptococcus salivarius Evol12®), Placebo
3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Oral and Pancreatobiliary Microbiota in Cancer: A Systematic Review of Compositional Alterations and Their Clinical Implications.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Pharmacomicrobiomics-driven targeted drug delivery for precision microbiome modulation.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  12. Review
  13. Article
  14. Caries burden and high-risk subgroups in children and adolescents with cerebral palsy in Türkiye.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2026
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John J RajasekaranVibrant Sciences LLC, Santa Clara, CA 95054, USA.
Hari Krishnan KrishnamurthyVibrant Sciences LLC, Santa Clara, CA 95054, USA.ORCID 0000-0002-7832-8423
Jophi BoscoVibrant America LLC, Santa Clara, CA 95054, USA.
Vasanth JayaramanVibrant Sciences LLC, Santa Clara, CA 95054, USA.
Karthik KrishnaVibrant Sciences LLC, Santa Clara, CA 95054, USA.
Tianhao WangVibrant Sciences LLC, Santa Clara, CA 95054, USA.
Kang BeiVibrant Sciences LLC, Santa Clara, CA 95054, USA.

Funding

Vibrant America NA
6 · The paper itself

Abstract

purpose of reviewThis review investigates the oral microbiome's composition, functions, influencing factors, connections to oral and systemic diseases, and personalized oral care strategies. RECENT

findingsThe oral microbiome is a complex ecosystem consisting of bacteria, fungi, archaea, and viruses that contribute to oral health. Various factors, such as diet, smoking, alcohol consumption, lifestyle choices, and medical conditions, can affect the balance of the oral microbiome and lead to dysbiosis, which can result in oral health issues like dental caries, gingivitis, periodontitis, oral candidiasis, and halitosis. Importantly, our review explores novel associations between the oral microbiome and systemic diseases including gastrointestinal, cardiovascular, endocrinal, and neurological conditions, autoimmune diseases, and cancer. We comprehensively review the efficacy of interventions like dental probiotics, xylitol, oral rinses, fluoride, essential oils, oil pulling, and peptides in promoting oral health by modulating the oral microbiome. SUMMARY: This review emphasizes the critical functions of the oral microbiota in dental and overall health, providing insights into the effects of microbial imbalances on various diseases. It underlines the significant connection between the oral microbiota and general health. Furthermore, it explores the advantages of probiotics and other dental care ingredients in promoting oral health and addressing common oral issues, offering a comprehensive strategy for personalized oral care.

Indexed as

dysbiosisoral careoral diseasesoral microbiomeoral microbiotaprobioticssystemic diseases

Identifiers

PMID39338471
PMCPMC11434369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.